Jefferies Cuts Price Target on DaVita (DVA) to $70; Reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- US stock index futures subdued as oil, Treasury yields rise on Iran tensions
- Oil prices steady as traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Dollar hits two-week high, Middle East conflict and rate paths in focus
- Is the ECB’s hawkish shift just beginning to bite? UBS weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
DaVita Clinical Research to Present 12 Abstracts at American Society of Nephrology Kidney Week 2016
November 14, 2016 12:41 PM ESTCHICAGO, Nov. 14, 2016 /PRNewswire/ -- DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development, today announced that company representatives and collaborators will present 12 abstracts at American Society of Nephrology (ASN) Kidney Week in Chicago, Nov. 15-20. Attendees can meet representatives of DaVita Clinical Research and... More
